Locations:
Search
Consider each patient's unique disease progression and treatment goals when choosing a strategy
Findings show greater reduction in CKD progression, kidney failure than GLP-1RAs
Identifying barriers in the renal genetic assessment of Black patients
Screening and medication key to better outcomes
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
NIH-funded study explores novel MRI technique to stage cystic kidney disease
Using sequencing data to identify novel factors linked to kidney disease with unknown origin
Understanding of genetic kidney disease has significantly increased in past five years
Investigators analyze dysnatremias using the Chronic Renal Insufficiency Cohort (CRIC) Study
Cleveland Clinic nephrologist and site PI distills its significance and offers considerations
New retrospective analysis of clinical trial data provide some reassurance regarding the safety of aspirin in patients with CKD
Advertisement
Advertisement